-
1
-
-
34247579714
-
A tumor suppressor and oncogene: The WT1 story
-
Yang L, Han Y, Suarez Saiz F, et al. A tumor suppressor and oncogene: the WT1 story. Leukemia 2007; 21: 868-76.
-
(2007)
Leukemia
, vol.21
, pp. 868-876
-
-
Yang, L.1
Han, Y.2
Suarez Saiz, F.3
-
2
-
-
33749031535
-
The many facets of the Wilms' tumour gene, WT1
-
Hohenstein P, Hastie ND. The many facets of the Wilms' tumour gene, WT1. Hum Mol Genetics 2006; 15: R196-201.
-
(2006)
Hum Mol Genetics
, vol.15
-
-
Hohenstein, P.1
Hastie, N.D.2
-
3
-
-
2942729674
-
Wilms tumor gene product. Sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin
-
Hwang H, Quenneville L, Yaziji H, et al. Wilms tumor gene product. Sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin. Appl Immunohistochem Mol Morphol 2004; 12: 122-6.
-
(2004)
Appl Immunohistochem Mol Morphol
, vol.12
, pp. 122-126
-
-
Hwang, H.1
Quenneville, L.2
Yaziji, H.3
-
4
-
-
1642398624
-
WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium
-
Acs G, Pasha T, Zhang PJ. WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium. Int J Gynecol Pathol 2004; 23: 110-8.
-
(2004)
Int J Gynecol Pathol
, vol.23
, pp. 110-118
-
-
Acs, G.1
Pasha, T.2
Zhang, P.J.3
-
5
-
-
33644520931
-
Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer
-
Hylander B, Repasky E, Shrikant P, et al. Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer. Gynecol Oncol 2006; 101: 12-7.
-
(2006)
Gynecol Oncol
, vol.101
, pp. 12-17
-
-
Hylander, B.1
Repasky, E.2
Shrikant, P.3
-
6
-
-
1542270080
-
WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma
-
Al-Hussaini M, Stockman A, Foster H, et al. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology 2004; 44: 109-15.
-
(2004)
Histopathology
, vol.44
, pp. 109-115
-
-
Al-Hussaini, M.1
Stockman, A.2
Foster, H.3
-
7
-
-
0141680966
-
Wilms gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum
-
Hashi A, Yuminamochi T, Murata S, et al. Wilms gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum. Int J Gynecol Pathol 2003; 22: 374-7.
-
(2003)
Int J Gynecol Pathol
, vol.22
, pp. 374-377
-
-
Hashi, A.1
Yuminamochi, T.2
Murata, S.3
-
8
-
-
33646895848
-
Immunohistochemical detection of WT1 protein in a variety of cancer cells
-
Nakatsuka S-i, Oji Y, Horiuchi T, et al. Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 2006; 19: 804-14.
-
(2006)
Mod Pathol
, vol.19
, pp. 804-814
-
-
Nakatsuka, S.-I.1
Oji, Y.2
Horiuchi, T.3
-
9
-
-
11844275908
-
Immunohistocheical expression of Wilms tumor gene protein in different histologic subtypes of ovarian carcinomas
-
Waldstrom M, Grove A. Immunohistocheical expression of Wilms tumor gene protein in different histologic subtypes of ovarian carcinomas. Arch Pathol Lab Med 2005; 129: 85-8.
-
(2005)
Arch Pathol Lab Med
, vol.129
, pp. 85-88
-
-
Waldstrom, M.1
Grove, A.2
-
10
-
-
0034004365
-
Immunohistochemical detection of the Wims' tumor gene (WT1) in epithelial ovarian tumors
-
Shimizu M, Toki T, Takagi Y, et al. Immunohistochemical detection of the Wims' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol 2000; 19: 158-63.
-
(2000)
Int J Gynecol Pathol
, vol.19
, pp. 158-163
-
-
Shimizu, M.1
Toki, T.2
Takagi, Y.3
-
11
-
-
34547137183
-
Expression of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer from the Danish 'MALOVA' study
-
Hogdall EVS, Christensen L, Kjaer SK, et al. Expression of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer from the Danish 'MALOVA' study. Gynecol Oncol 2007; 106: 318-24.
-
(2007)
Gynecol Oncol
, vol.106
, pp. 318-324
-
-
Hogdall, E.V.S.1
Christensen, L.2
Kjaer, S.K.3
-
12
-
-
0142232026
-
Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers. Histogenetic and diagnostic implications
-
Logani S, Oliva E, Amin MB, et al. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers. Histogenetic and diagnostic implications. Am J Surg Pathol 2003; 27: 1434-41.
-
(2003)
Am J Surg Pathol
, vol.27
, pp. 1434-1441
-
-
Logani, S.1
Oliva, E.2
Amin, M.B.3
-
13
-
-
14644435815
-
The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors
-
Cathro HP, Stoler MH. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors. Hum Pathol 2005; 36: 195-201.
-
(2005)
Hum Pathol
, vol.36
, pp. 195-201
-
-
Cathro, H.P.1
Stoler, M.H.2
-
14
-
-
0034761120
-
WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms
-
Goldstein NS, Bassi D, Uzieblo A. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. Am J Clin Pathol 2001; 116: 246-52.
-
(2001)
Am J Clin Pathol
, vol.116
, pp. 246-252
-
-
Goldstein, N.S.1
Bassi, D.2
Uzieblo, A.3
-
15
-
-
0036233031
-
WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids
-
Lee BH, Hecht JL, Pinkus JL, Pinkus GS. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids. Am J Clin Pathol 2002; 117: 745-50.
-
(2002)
Am J Clin Pathol
, vol.117
, pp. 745-750
-
-
Lee, B.H.1
Hecht, J.L.2
Pinkus, J.L.3
Pinkus, G.S.4
-
16
-
-
27244443408
-
Expression of WT1, CA125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary
-
Tornos C, Soslow R, Chen S, et al. Expression of WT1, CA125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol 2005; 29: 1482-9.
-
(2005)
Am J Surg Pathol
, vol.29
, pp. 1482-1489
-
-
Tornos, C.1
Soslow, R.2
Chen, S.3
-
17
-
-
34249739090
-
WT1, monoclonal CEA, TTF-1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions
-
Zhu W, Michael CW. WT1, monoclonal CEA, TTF-1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions. Diagn Cytopathol 2007; 35: 370-5.
-
(2007)
Diagn Cytopathol
, vol.35
, pp. 370-375
-
-
Zhu, W.1
Michael, C.W.2
-
18
-
-
22944470552
-
Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps
-
Euscher ED, Malpica A, Deavers MT, et al. Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps. Am J Surg Pathol 2005; 29: 1074-8.
-
(2005)
Am J Surg Pathol
, vol.29
, pp. 1074-1078
-
-
Euscher, E.D.1
Malpica, A.2
Deavers, M.T.3
-
19
-
-
0036329040
-
WT-1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas
-
Goldstein NS, Uzieblo A. WT-1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. Am J Clin Pathol 2002; 117: 541-5.
-
(2002)
Am J Clin Pathol
, vol.117
, pp. 541-545
-
-
Goldstein, N.S.1
Uzieblo, A.2
-
20
-
-
1642304419
-
WT1 is of value in ascertaining the site of origin of serous carcinomas within the female genital tract
-
McCluggage WG. WT1 is of value in ascertaining the site of origin of serous carcinomas within the female genital tract. Int J Gynecol Pathol 2004; 23: 97-9.
-
(2004)
Int J Gynecol Pathol
, vol.23
, pp. 97-99
-
-
McCluggage, W.G.1
-
21
-
-
4644266635
-
WT-staining in endometrial serous carcinomas
-
Golstein NS. WT-staining in endometrial serous carcinomas. Int J Gynecol Pathol 2004; 23: 405-12.
-
(2004)
Int J Gynecol Pathol
, vol.23
, pp. 405-412
-
-
Golstein, N.S.1
-
22
-
-
33745067420
-
WT1 gene expression as a prognostic marker in advanced serous carcinoma: An immunohistochemical study
-
Netinatsunthorn W, Hanprasertpong J, Dechsukhum C, et al. WT1 gene expression as a prognostic marker in advanced serous carcinoma: an immunohistochemical study. BMC Cancer 2006; 6: 90.
-
(2006)
BMC Cancer
, vol.6
, pp. 90
-
-
Netinatsunthorn, W.1
Hanprasertpong, J.2
Dechsukhum, C.3
-
23
-
-
35748982942
-
Clinicopathological significance of WT1 expression in ovarian cancer: A possible accelerator of tumor progression in serous adenocarcinoma
-
Yamamoto S, Tsuda H, Kita T, et al. Clinicopathological significance of WT1 expression in ovarian cancer: a possible accelerator of tumor progression in serous adenocarcinoma. Virchows Arch 2007; 451: 27-35.
-
(2007)
Virchows Arch
, vol.451
, pp. 27-35
-
-
Yamamoto, S.1
Tsuda, H.2
Kita, T.3
-
24
-
-
33947322028
-
Immunotherapeutic targeting of Wilms' tumor protein
-
Hutchings Y, Osada T, Woo CY, et al. Immunotherapeutic targeting of Wilms' tumor protein. Curr Opin Mol Ther 2007; 9: 62-9.
-
(2007)
Curr Opin Mol Ther
, vol.9
, pp. 62-69
-
-
Hutchings, Y.1
Osada, T.2
Woo, C.Y.3
-
25
-
-
24744451843
-
Cancer immunotherapy targeting Wilms' tumor gene WT1 product
-
Sugiyama H. Cancer immunotherapy targeting Wilms' tumor gene WT1 product. Expert Rev Vaccines, 2005; 4: 503-12.
-
(2005)
Expert Rev Vaccines
, vol.4
, pp. 503-512
-
-
Sugiyama, H.1
-
26
-
-
38849097832
-
My approach to and thoughts on the typing of ovarian carcinomas
-
McCluggage WG. My approach to and thoughts on the typing of ovarian carcinomas. J Clin Pathol 2008; 61: 152-63.
-
(2008)
J Clin Pathol
, vol.61
, pp. 152-163
-
-
McCluggage, W.G.1
-
27
-
-
0037216292
-
Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in ovarian endometriosis
-
Prefumo F, Venturini PL, Fulcheri E. Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in ovarian endometriosis. Int J Gynecol Pathol 2002; 22: 83-8.
-
(2002)
Int J Gynecol Pathol
, vol.22
, pp. 83-88
-
-
Prefumo, F.1
Venturini, P.L.2
Fulcheri, E.3
-
28
-
-
0029164446
-
The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis
-
Maheswaran S, Englert C, Bennett P, et al. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Develop 1995; 9: 2143-56.
-
(1995)
Genes Develop
, vol.9
, pp. 2143-2156
-
-
Maheswaran, S.1
Englert, C.2
Bennett, P.3
-
29
-
-
0034243425
-
FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology
-
Benedet JL, Bender H, Jones III H, et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynecol Obstet 2000; 70: 209-62.
-
(2000)
Int J Gynecol Obstet
, vol.70
, pp. 209-262
-
-
Benedet, J.L.1
Bender, H.2
Jones III, H.3
-
30
-
-
21544468606
-
Synchronous endometrial and ovarian tumors: Metastatic disease or independent primaries?
-
Robboy SJ, Dano MB. Synchronous endometrial and ovarian tumors: metastatic disease or independent primaries? Hum Pathol 2005; 36: 597-9.
-
(2005)
Hum Pathol
, vol.36
, pp. 597-599
-
-
Robboy, S.J.1
Dano, M.B.2
-
31
-
-
1642398622
-
Interpretation of p53 immunoreactivity in endometrial carcinoma: Establishing a clinically relevant cut-off level
-
Alkushi A, Lim P, Coldman A, et al. Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level. Int J Gynecol Pathol 2004; 23: 129-37.
-
(2004)
Int J Gynecol Pathol
, vol.23
, pp. 129-137
-
-
Alkushi, A.1
Lim, P.2
Coldman, A.3
-
32
-
-
12844255771
-
Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: A report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms
-
Murray SK, Clement PB, Young RH. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms. Am J Surg Pathol 2005; 29: 157-66.
-
(2005)
Am J Surg Pathol
, vol.29
, pp. 157-166
-
-
Murray, S.K.1
Clement, P.B.2
Young, R.H.3
-
33
-
-
0023202069
-
Evaluation of the reproducibility of the World Health Organization classification of common ovarian cancers
-
Cramer SF, Roth LM, Ulbright TM, et al. Evaluation of the reproducibility of the World Health Organization classification of common ovarian cancers. Arch Pathol Lab Med 1987; 111: 819-29.
-
(1987)
Arch Pathol Lab Med
, vol.111
, pp. 819-829
-
-
Cramer, S.F.1
Roth, L.M.2
Ulbright, T.M.3
-
34
-
-
0026007984
-
The diagnosis of ovarian cancer by pathologists: How often do diagnoses by contributing pathologists agree with a panel of gynecologic pathologists?
-
Tyler CW, Lee NC, Robboy SJ, et al. The diagnosis of ovarian cancer by pathologists: how often do diagnoses by contributing pathologists agree with a panel of gynecologic pathologists? Am J Obstet Gynecol 1991; 164: 65-70.
-
(1991)
Am J Obstet Gynecol
, vol.164
, pp. 65-70
-
-
Tyler, C.W.1
Lee, N.C.2
Robboy, S.J.3
-
35
-
-
3042737680
-
Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data
-
Gilks CB. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data. Int J Gynecol Pathol 2004; 23: 200-5.
-
(2004)
Int J Gynecol Pathol
, vol.23
, pp. 200-205
-
-
Gilks, C.B.1
-
36
-
-
34249991721
-
Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomas
-
Coosemans A, Amini Nik A, Caluwaerts S, et al. Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomas. Eur J Cancer 2007; 43: 1630-7.
-
(2007)
Eur J Cancer
, vol.43
, pp. 1630-1637
-
-
Coosemans, A.1
Amini Nik, A.2
Caluwaerts, S.3
-
37
-
-
0035123775
-
Precursor lesions of ovarian epithelial malignancy
-
Feeley KM, Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology 2001; 38: 87-95.
-
(2001)
Histopathology
, vol.38
, pp. 87-95
-
-
Feeley, K.M.1
Wells, M.2
-
38
-
-
13244256870
-
Origins and molecular pathology of ovarian cancer
-
Bell DA. Origins and molecular pathology of ovarian cancer. Mod Pathol 2005; 18: S19-32.
-
(2005)
Mod Pathol
, vol.18
-
-
Bell, D.A.1
-
39
-
-
2942729440
-
Endometriosis and the develpoment of malignant tumours of the pelvis. A review of literature
-
Van Gorp T, Amant F, Neven P, et al. Endometriosis and the develpoment of malignant tumours of the pelvis. A review of literature. Best Pract Res Clin Obstet Gynaecol 2004; 18: 349-71.
-
(2004)
Best Pract Res Clin Obstet Gynaecol
, vol.18
, pp. 349-371
-
-
Van Gorp, T.1
Amant, F.2
Neven, P.3
-
40
-
-
4644237062
-
Recent advances in endometriosis with emphasis on pathogenesis, molecular pathology, and neoplastic transformation
-
Wells M. Recent advances in endometriosis with emphasis on pathogenesis, molecular pathology, and neoplastic transformation. Int J Gynecol Pathol 2004; 23: 316-20.
-
(2004)
Int J Gynecol Pathol
, vol.23
, pp. 316-320
-
-
Wells, M.1
-
41
-
-
0033768219
-
A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary
-
Bell KA, Kurman RJ. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary. Am J Surg Pathol 2000; 24: 1465-79.
-
(2000)
Am J Surg Pathol
, vol.24
, pp. 1465-1479
-
-
Bell, K.A.1
Kurman, R.J.2
-
42
-
-
0041887074
-
Ovarian endometrioid tumors of low malignant potential. A clinicopathologic study of 30 cases with comparison to well-differentiated endometrioid adenocarcinoma
-
Roth LM, Emerson RE, Ulbright TM. Ovarian endometrioid tumors of low malignant potential. A clinicopathologic study of 30 cases with comparison to well-differentiated endometrioid adenocarcinoma. Am J Surg Pathol 2003; 27: 1253-9.
-
(2003)
Am J Surg Pathol
, vol.27
, pp. 1253-1259
-
-
Roth, L.M.1
Emerson, R.E.2
Ulbright, T.M.3
-
43
-
-
0036218164
-
Role of endometriosis in cancer and tumor development
-
Swiersz LM. Role of endometriosis in cancer and tumor development. Ann NY Acad Sci 2002; 955: 281-92.
-
(2002)
Ann NY Acad Sci
, vol.955
, pp. 281-292
-
-
Swiersz, L.M.1
-
44
-
-
10044266232
-
Molecular genetic alterations in endometrioid carcinomas of the ovary: Similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas
-
Catasus L, Bussaglia E, Rodriguez I, et al. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Hum Pathol 2004; 35: 1360-8.
-
(2004)
Hum Pathol
, vol.35
, pp. 1360-1368
-
-
Catasus, L.1
Bussaglia, E.2
Rodriguez, I.3
-
45
-
-
0019995285
-
Ovarian endometrioid carcinomas resembling sex cord-stromal tumors: A clinicopathologic analysis of 13 cases
-
Young RH, Prat J, Scully RE. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors: a clinicopathologic analysis of 13 cases. Am J Surg Pathol 1982; 6: 513-22.
-
(1982)
Am J Surg Pathol
, vol.6
, pp. 513-522
-
-
Young, R.H.1
Prat, J.2
Scully, R.E.3
-
46
-
-
0024453985
-
Ovarian endometrioid carcinomas resembling sex cord-stromal tumors
-
Aguirre P, Thor AD, Scully RE. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. Int J Gynecol Pathol 1989; 8: 364-73.
-
(1989)
Int J Gynecol Pathol
, vol.8
, pp. 364-373
-
-
Aguirre, P.1
Thor, A.D.2
Scully, R.E.3
-
47
-
-
0345515974
-
Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: A study using inhibin and cytokeratin 7
-
Guerrieri C, Franlund B, Malmstrom H, Boeryd B. Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7. Int J Gynecol Pathol 1998; 17: 266-71.
-
(1998)
Int J Gynecol Pathol
, vol.17
, pp. 266-271
-
-
Guerrieri, C.1
Franlund, B.2
Malmstrom, H.3
Boeryd, B.4
-
48
-
-
0031596443
-
Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors
-
Matias-Guiu X, Pons C, Prat J. Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Hum Pathol 1998; 29: 840-9.
-
(1998)
Hum Pathol
, vol.29
, pp. 840-849
-
-
Matias-Guiu, X.1
Pons, C.2
Prat, J.3
-
49
-
-
34250836984
-
Sertoliform endometrioid carcinoma of the endometrium with dual immunophenotypes for epithelial membrane antigen and inhibin alpha: Case report and literature review
-
Liang SX, Patel K, Pearl M, et al. Sertoliform endometrioid carcinoma of the endometrium with dual immunophenotypes for epithelial membrane antigen and inhibin alpha: case report and literature review. Int J Gynecol Pathol 2007; 26: 291-7.
-
(2007)
Int J Gynecol Pathol
, vol.26
, pp. 291-297
-
-
Liang, S.X.1
Patel, K.2
Pearl, M.3
|